Test your rare disease marketing knowledge. Discover myths, facts, and best practices for engaging patients early, addressing unmet needs, and effectively amplifying their voices.

Klick Strategy Team

Uncovering the Realities of Rare Disease Marketing—Take The Quiz

Oncology is looking more and more like a rare disease in its treatment, with a shift towards hyper-personalized care and deploying digital tools that empower patients, advocates, and care partners. Check out how Klick is leading this transformation with precision strategies and integrated engagement expertise to reshape cancer care.

Brad Aufderheide

Cancer’s Rare Evolution: Why Oncology Is Borrowing from Rare Disease Playbooks

Discover the true impact of rare disease and the urgent need for innovation through data that challenges misconceptions and highlights unmet needs.

What the Data Says About Rare Diseases

Review our recommendations for a unique approach to rare disease marketing to recognize the distinct challenges and nuances that set it apart from traditional healthcare marketing strategies. 

Reinventing the Playbook, Rare Disease is Different

AI is transforming medical affairs and driving engagement. To stay ahead, teams must embrace AI, upskill, and adapt. Read the full article for post-conference insights from the 2025 AI in Medical Affairs Summit.

Quentin O'Brien

Unleashing AI in Medical Affairs: Insights from the Fourth Annual AI in Medical Affairs Summit

Email marketing is evolving with AI, personalization, and adjusting to more stringent data privacy. Stay compliant, engaging, and future-ready with these best practices.

Edna Cheung

Email’s Evolution: How the Launch of Apple iOS 18 is Changing the Email Landscape

At Klick, we challenge conventional strategies by integrating data, technology, and humanistic approaches. Our "Difference-Making Strategy" series reimagines strategy as a dynamic, evolving practice. Through a series of explorations, we invite you to join us in redefining strategic thinking to navigate today's rapidly changing marketplace.

Brian Kaiser

Introducing Difference-Making Strategy

This POV examines how generative AI transforms pharma by boosting efficiency, enabling hybrid AI-human workflows, and paving the way for agentic AI to manage entire processes.

Simon Smith

Brian Fox

How AI Is Transforming Life Sciences Commercialization

Explore the Veeva-Salesforce split and discover what’s changing for each platform as they enhance AI, patient and HCP engagement, and solutions tailored for life sciences.

発見

Stay Informed with the Klick Wire